BiotechTube
IBT Bioservices

IBT Bioservices

Rockville, United States· Est.
ibtbioservices.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

IBT Bioservices is a US-based, privately-held CRO offering integrated preclinical and clinical testing services, primarily for biopharma and vaccine developers. Its core expertise lies in virology and bacteriology, providing a comprehensive suite from custom assay development and animal models to GxP-compliant release testing. The company has established a diversified business model combining high-margin reagent sales with fee-for-service contracts, supported by a global distributor network and strategic partnerships with organizations like Twist Bioscience and the Sabin Vaccine Institute.

Infectious DiseasesImmunology

Technology Platform

Integrated CRO platform specializing in virology/bacteriology, including pseudovirus production, custom assay development & validation, in vivo infection models, and GxP-compliant testing services.

Opportunities

Growing global focus on pandemic preparedness and biodefense drives demand for specialized infectious disease CRO services and reagents.
Expansion of GMP/GLP service offerings can capture higher-value work from late-stage clinical and commercial clients.
Leveraging its distributor network to grow reagent sales globally presents a scalable, high-margin revenue stream.

Risk Factors

Revenue is project-dependent and susceptible to shifts in client R&D budgets, particularly in infectious disease.
Intense competition from larger, full-service CROs and niche specialists requires continuous differentiation.
Operational risks include maintaining stringent biosafety protocols for high-consequence pathogens and adhering to evolving GxP regulations.

Competitive Landscape

IBT competes in the fragmented preclinical CRO market against giants like Charles River Laboratories and Labcorp, as well as numerous specialized boutiques. Its primary competitive advantage is deep expertise in high-containment pathogen research and a fully integrated service model from discovery to clinical release. Competitors in the reagent space include dedicated antibody companies and large distributors that also produce in-house brands.

More companies in Digital Health & Biotech SaaS →More companies in United States →